期刊文献+

芪苈强心胶囊对心力衰竭患者心功能影响的超声研究 被引量:5

Ultrasound Study on the Cardiac Function Treated with Qili Qiangxin Capsule in Patients with Chronic Heart Failure
下载PDF
导出
摘要 目的利用超声探讨芪苈强心胶囊对心力衰竭患者心功能的影响。方法选择80例充血性心力衰竭患者并随机分成芪苈强心胶囊组和常规治疗对照组,分别于治疗前、治疗后15天、治疗后30天用超声测量左室收缩和舒张功能及各项指标。结果对照组LVEDV及LVESV仅在治疗后30天均明显减少(P<0.05),芪苈强心胶囊治疗组LVEDV和LVESV治疗后15天及30天较治疗前均明显减少(P<0.05),且芪苈强心胶囊治疗组治疗后15天和治疗后30天与对照组比较差异有有统计学意义(P<0.05)。两组收缩和舒张功能指标治疗后有不同程度的改善,但以芪苈强心胶囊组改善明显,数据差异具有统计学意义(P<0.05)。结论芪苈强心胶囊可抑制充血性心力衰竭患者的左室重构,改善左室收缩和舒张功能。 Objective To investigate the cardiac function-in chronic heart failure patients treated with Qili Qiangxin capsule (QLQX). Methods 80 patients with heart failure were divided into the treatment group (QLQX treatment) and control group (conventional treatment). Cardiac function was measured by ultrasound in two groups. Results Compared with prior treatment, the LVEDV and LVESV decreased 30 d after treatment in control group, while 15 d and 30 d after treatment in the QLQX group (P〈0.05); the differences of LVEDV and LVESV between two groups 15 d and 30 d after treatment were statistically significant (P〈0.05); the cardiac systolic and diastolic function improved in both groups, but the QLQX group was better than control group (P〈0.05). Conclusions QLQX can inhibit the left ventricular remodeling in chronic heart failure patients, and improve the cardiac systolic and diastolic function.
作者 陈婕 陈兵勇
出处 《临床医学工程》 2013年第6期652-653,共2页 Clinical Medicine & Engineering
关键词 芪苈强心胶囊 心力衰竭 超声 Qili Qiangxin capsule Chronic heart failure Ultrasound
  • 相关文献

参考文献7

二级参考文献50

共引文献87

同被引文献60

  • 1刘亚军.芪苈强心胶囊辅助治疗老年人心梗后心力衰竭的疗效观察[J].医药前沿,2012;02(19) :192-193.
  • 2Li X, Zhang J, Huang J, et al. A multicenter, randomized, double- blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure [J] . J Am Coll Cardiol, 2013, 62 (12) : 1065-1072.
  • 3Tang WH, Huang Y. Cardiotonic modulation in heart failure: insights from traditional Chinese medicine [J] . J Am Coll Cardiol, 2013, 62 (12): 1073-1074.
  • 4Zhang JM,Liu XC.Comparison of effects of extrathoracic paraaortic counterpulsation to intraaortic balloon pump on circulatory support in acute heart failure[J].J Cardiothorac Surg,2015,10(1):173.
  • 5Messias LR,Messias AC,de Miranda SM,et al.Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction[J].Int J Cardiol,2015,203:900-2.
  • 6Shi L,Xie Y,Liao X,et al.Shenmai injection as an adjuvant treatment for chronic corpulmonale heart failure:a systematic review and meta-analysis of randomized controlled trials[J].BMC Complement Altern Med,2015,15(1):418.
  • 7Baig M,Wool KJ,Halanych JH,et al Acute Liver Failure after Initiation of Rivaroxaban:A Case Report and Review of the Literature[J].N Am J Med Sci,2015,7(9):407-410.
  • 8Namiuchi S,Sugie T,Kato A.Letter in reply:Glasgow Prognostic Score in heart failure,how can we use it?[J].J Cardiovasc Med(Hagerstown),2016,17(1):70-1.
  • 9徐贵成,王秋风,刘坤,尹倚艰.芪苈强心胶囊治疗慢性收缩性心力衰竭的临床研究[J].疑难病杂志,2008,7(5):262-265. 被引量:28
  • 10龙飞,江珊.芪苈强心胶囊治疗慢性心力衰竭的临床观察[J].辽宁中医杂志,2009,36(4):582-583. 被引量:20

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部